[1]
Aiyere, E.O. et al. 2014. Clinical Trial Risk in Type-2 Diabetes: Importance of Patient History. Journal of Pharmacy & Pharmaceutical Sciences. 17, 3 (Aug. 2014), 393–400. DOI:https://doi.org/10.18433/J3HG73.